Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, October 23, 2026

Back to today

From X

@StableBread

Fajasy on X

Revenue at Nubeva Technologies $NBVAF (TSXV: $NBVA) has fallen 76% since 2023, but it still has ~4 years of cash. Since losing Kroll, its biggest customer, Nubeva’s revenue has dropped from its FY2023 high of $2.07M. Expenses fell 66% over the same period, from $4.03M to $1.36M. Nubeva booked $500,586 in FY2026, across three revenue lines: 1) Software licenses ($204,055, 41% of revenue): Attributed in the MD&A “primarily” to NuRR, its ransomware-recovery product. 2) Subscriptions ($90,819, 18%): NuRR, down from $113,356 in FY2025. The December 2025 interim MD&A blamed the decline on fewer customers renewing. 3) Support and maintenance ($205,712, 41%): The last TLS (web-traffic decryption) customer, paying under a source-code and distribution agreement Nubeva kept when it sold its TLS technology in March 2024. Just two customers made up 82% of FY2026 revenue (41% each). While the concentration risk exists, both customers have continued working with Nubeva. The TLS customer has been paying since before the March 2024 sale, and the license customer since FY2025. Nubeva ended FY2026 with $2,489,316 of cash and money-market funds and no debt beyond a $12,262 pandemic-era SBA loan. Cash fell $600,162 over the year, which means runway is ~4 years ($2,489,316 / $600,162) if nothing material changes. CEO Randy Chou didn’t expect Nubeva to burn cash in 2025. In a March 4, 2024 video posted the day the TLS sale closed, he said the sale would make Nubeva cash-flow positive for calendar 2024, with 2025 “targeted to be the same.” Instead, cash fell $457,706 in the 12 months to January 31, 2026, the closest reported period to calendar 2025 ($3,184,879 to $2,727,173). In other words, the TLS sale didn’t make Nubeva self-funding, so the ~4-year runway is how long Chou has to automate support or sell. Even if both top customers churned, cash would still cover ~2.5 years of operations. Nubeva hasn’t raised equity since a CAD$1.59M private placement in February 2022, and the last warrants expired in FY2025, so dilution has been minimal.

Investor Letters

All letters

Capital Wars

CoreWeave’s $35 billion to $39 billion 2026 spending plan relies on debt as unsecured yields reach 15%, making its GPU cloud expansion a…

CRWV $30B
Net Interest 11 clicks

Putting bear cases to rest

Medpace authorized $1 billion of buybacks through 2028 after Q3 revenue rose 8.5% to $716 million; service revenue grew roughly 12% as…

MEDP $18B
Best Anchor Stocks 14 clicks
PYPD · long

Polypid LTD

PolyPid, an $80 million Israeli biotech, fell nearly 30% despite solving a clinical problem.

PYPD $106M
Value Investors Club

MYR Group q3’26 Earnings Preview

MYR Group’s Q3 2026 preview cites data-center and power transmission demand, with long-term service agreements supporting margin growth and…

MYRG $4B
Monte Independent Investment Research 5 clicks

Mosaic, Part One: The Story

Mosaic’s history traces the 2004 Cargill-IMC merger and the phosphate and potash mines that shaped NYSE: MOS.

MOS $5.5B
Latticework by MOI Global 33 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 62 of 253

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.